Description: Provexis plc is engaged in developing and licensing the Fruitflow heart-health functional food ingredient for the global functional food sector. Fruitflow is a tomato extract, which inhibits platelet aggregation that causes heart attack, stroke and venous thrombosis. The syrup and powder versions of Fruitflow are used in foods, beverages and supplements. The powder version is used in a range of products, including soft gels, capsules, tablets and stick packs. The Company also offers Fruitflow + Omega-3 dietary supplement product, which is a two-in-one supplement in an easy to take capsule supporting healthy blood flow and normal heart function. Fruitflow + Omega-3 dietary supplement product is available through its e-commerce Website www.fruitflowplus.com. The Company's subsidiaries include Provexis Nutrition Limited, Provexis Natural Products Limited and Provexis (IBD) Limited, which are engaged in providing functional food, medical food and dietary supplement technologies.
Home Page: www.provexis.com
PXS Technical Analysis
2 Blagrave Street
Reading,
RG1 1AZ
United Kingdom
Phone:
44 7490 391 888
Officers
| Name | Title |
|---|---|
| Mr. Ian Ford BA (Hons) ACA | CEO, CFO, Company Sec. & Exec. Director |
| Dr. Niamh Ann O'Kennedy B.Sc., BSc, M.Sc., MSc, Ph.D. | Chief Scientific Officer, Member of Scientific Advisory Board & Exec. Director |
| Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN | Consultant & Member of Scientific Advisory Board |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.3575 |
| Price-to-Book MRQ: | 10.7704 |
| Price-to-Sales TTM: | 38.0165 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2 |